Alternative Splicing: A Potential Therapeutic Target in Hematological Malignancies

Alternative Splicing: A Potential Therapeutic Target in Hematological Malignancies

Leukemia represents the most prevalent malignancy in children, constituting 30% of childhood cancer cases, with acute lymphoblastic leukemia (ALL) being particularly heterogeneous. This paper explores the role of alternative splicing in leukemia, highlighting its significance in cancer development a...

Full description

Bibliographic Details
Main Authors: Gazmend Temaj, Silvia Chichiarelli, Sarmistha Saha, Pelin Telkoparan-Akillilar, Nexhibe Nuhii, Rifat Hadziselimovic, Luciano Saso
Format: Article
Language:English
Published: MDPI AG 2024-10-01
Series:Hematology Reports
Subjects:
hematologic cancers
alternative splicing factor
RNA splicing
therapeutics
Online Access:https://www.mdpi.com/2038-8330/16/4/66

Internet

https://www.mdpi.com/2038-8330/16/4/66

Similar Items